{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:32Z","timestamp":1792784492775,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018232","name":"University of Pennsylvania The Orphan Disease Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS127403-01A1"],"award-info":[{"award-number":["R01 NS127403-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01 NS127403-01A1"],"award-info":[{"award-number":["R01 NS127403-01A1"]}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001790","name":"Ara Parseghian Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Together Strong NPC Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymgme.2025.109180","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T02:45:13Z","timestamp":1750128313000},"page":"109180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseases"],"prefix":"10.1016","volume":"145","author":[{"given":"Pamela","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Gaudioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto R.","family":"Bongarzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109180_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ymgme.2025.109180_bb0010","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl. Sci. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109180_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12833","article-title":"Unifying biology of neurodegeneration in lysosomal storage diseases","volume":"48","author":"Ludlaim","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109180_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/diseases4040040","article-title":"Biomarkers in lysosomal storage diseases","volume":"4","author":"Bobillo Lobato","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.ymgme.2025.109180_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109180_bb0030","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1097\/MS9.0000000000002611","article-title":"Neurological manifestations of lysosomal storage diseases","volume":"86","author":"Elendu","year":"2024","journal-title":"Ann. Med. Surg. (Lond.)"},{"key":"10.1016\/j.ymgme.2025.109180_bb0035","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2025.109180_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072566","article-title":"Mechanism of secondary ganglioside and lipid accumulation in lysosomal disease","volume":"21","author":"Breiden","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109180_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2015.12.006","article-title":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","volume":"117","author":"Ferraz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109180_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2018.03.042","article-title":"The brain lipidome in neurodegenerative lysosomal storage disorders","volume":"504","author":"Fuller","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2025.109180_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","article-title":"Secondary accumulation of gangliosides in lysosomal storage disorders","volume":"15","author":"Walkley","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2025.109180_bb0060","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2025.109180_bb0065","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1042\/BST20240315","article-title":"Linking glycosphingolipid metabolism to disease-related changes in the plasma membrane proteome","volume":"52","author":"Monkhouse","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymgme.2025.109180_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40265-013-0164-6","article-title":"Miglustat: a review of its use in Niemann-Pick disease type C","volume":"74","author":"Lyseng-Williamson","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2025.109180_bb0075","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1194\/jlr.M040618","article-title":"Identification of Niemann-pick C1 disease biomarkers through sphingolipid profiling","volume":"54","author":"Fan","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109180_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100600","article-title":"Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1","volume":"65","author":"Mishra","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109180_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108615","article-title":"Clinical and biochemical abnormalities in a feline model of GM2 activator deficiency","volume":"144","author":"Beecy","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109180_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41419-023-05784-2","article-title":"Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency","volume":"14","author":"Gaudioso","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2025.109180_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.896314","article-title":"CRISPR-Cas9 knock-in of T513M and G41S mutations in the murine beta-galactosyl-ceramidase gene re-capitulates early-onset and adult-onset forms of Krabbe disease","volume":"15","author":"Rebiai","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymgme.2025.109180_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omtm.2017.07.005","article-title":"Lipidomic evaluation of feline neurologic disease after AAV gene therapy","volume":"6","author":"Gray-Edwards","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2025.109180_bb0105","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/jor.24803","article-title":"Abnormal epiphyseal development in a feline model of Sandhoff disease","volume":"38","author":"McNulty","year":"2020","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ymgme.2025.109180_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104627","article-title":"A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis","volume":"92","author":"Kell","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2025.109180_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4235","article-title":"A HILIC-MS\/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum","volume":"32","author":"Sidhu","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymgme.2025.109180_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","article-title":"Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)","volume":"126","author":"Wasserstein","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109180_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 gangliosidosis-a mini-review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2025.109180_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0043-1769115","article-title":"Genesis of a fact: Tay-Sachs disease as a \u201csimple recessive\u201d","volume":"12","author":"Lubinsky","year":"2023","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.ymgme.2025.109180_bb0135","series-title":"GeneReviews\u00ae [Internet]","article-title":"Sandhoff disease","author":"Xiao","year":"2022"},{"key":"10.1016\/j.ymgme.2025.109180_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135841","article-title":"Krabbe disease: new hope for an old disease","volume":"752","author":"Bradbury","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2025.109180_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2024.11.001","article-title":"Emerging biomarkers in Gaucher disease","volume":"124","author":"Luettel","year":"2025","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.ymgme.2025.109180_bb0150","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109180_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165875","article-title":"Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: opportunities for shared therapeutic interventions","volume":"1866","author":"Yanez","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymgme.2025.109180_bb0160","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.221739","article-title":"Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases","volume":"132","author":"Marques","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2025.109180_bb0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-biochem-092823-113814","article-title":"The bis(monoacylglycero)-phosphate hypothesis: from lysosomal function to therapeutic avenues","volume":"93","author":"Medoh","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymgme.2025.109180_bb0170","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1194\/jlr.M057851","article-title":"Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses","volume":"56","author":"Akgoc","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109180_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109180_bb0180","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.RA119000157","article-title":"N-acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease","volume":"60","author":"Sidhu","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109180_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20071043","article-title":"Effect of lysosomal storage on bis(monoacylglycero)phosphate","volume":"411","author":"Meikle","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2025.109180_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.plefa.2009.09.006","article-title":"Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: implications in pathology","volume":"81","author":"Hullin-Matsuda","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ymgme.2025.109180_bb0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2760(96)00040-9","article-title":"Mammalian platelet-activating factor acetylhydrolases","volume":"1301","author":"Stafforini","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2025.109180_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/mol.108.051003","article-title":"Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation","volume":"75","author":"Welch","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymgme.2025.109180_bb0205","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.molcel.2022.03.026","article-title":"Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation","volume":"82","author":"Gao","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgme.2025.109180_bb0210","series-title":"Handbook of Neurochemistry and Molecular Neurobiology","first-page":"311","article-title":"Metabolism and functions of platelet-activating factor (PAF) in the nervous tissue","author":"Goracci","year":"2009"},{"key":"10.1016\/j.ymgme.2025.109180_bb0215","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109180_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0005-2760(87)90314-6","article-title":"The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla","volume":"920","author":"Kawasaki","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2025.109180_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0076-6879(07)34006-8","article-title":"Platelet-activating factor","volume":"434","author":"Owen","year":"2007","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2025.109180_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N. Engl. J. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:48:54Z","timestamp":1778590134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1096719225001714"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109180","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109180"}}